Ying Han
Gyre Therapeutics, Inc. · Chief Executive Officer
Ying Han is listed in filings as Chief Executive Officer at Gyre Therapeutics, Inc.. This profile follows SEC Form 4 activity through Aug 16, 2024, including 1 public disclosure. Recent filings connect the profile to Gyre Therapeutics, Inc. (GYRE). The current snapshot covers public activity from Aug 16, 2024. Reported amounts are shown as $3.4M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| No direct insider buys or sells are available yet. | ||||